 Turning Point Therapeutics TPTX stock is rocketing higher on Friday following news of a deal with Bristol-Myers Squibb BMY. The post TPTX Stock Soars 115 as Bristol Myers Announces Takeover of Turning Point Therapeutics appeared first on InvestorPlace. 